Tenaya Therapeutics, Inc. (TNYA) Corporate Subsidiaries
Tenaya Therapeutics, Inc. (TNYA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TNYA
CIK: 1858848
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerKelsey Yuan
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-13 | 2026-12-09 | PRE 14A | 0001193125-26-420540 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 | 0001193125-26-389563 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 | 0001193125-26-389561 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-24 | — | SCHEDULE 13G Filing | 0001104659-26-100403 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-17 | 4 | 0001193125-26-354518 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-17 | 4 | 0001193125-26-354517 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001193125-26-354513 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001193125-26-354511 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | S-8 | 0001193125-26-335231 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335140 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335098 | View SEC Doc Filr Page |
| 3 | 2026-07-14 | 2026-07-13 | 3 | 0001193125-26-303682 | View SEC Doc Filr Page |
| 4 | 2026-07-14 | 2026-07-13 | 4 | 0001193125-26-303681 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-29 | 8-K | 0001193125-26-294879 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001193125-26-286957 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-249135 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-249132 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-249131 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-249116 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-249114 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-249113 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001193125-26-249052 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-27 | 8-K | 0001193125-26-248680 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-18 | 4 | 0001193125-26-231324 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-18 | 4 | 0001193125-26-231323 | View SEC Doc Filr Page |